When combined with more conventional in vitro cell manipulation approaches, these new tools should hopefully facilitate the identification of both the cellular function of PrP and signaling pathways critical for neurotoxicity in AD and prion diseases. This evidence concerns the gene PRNP and Alzheimer disease.